(Q41365905)

29 September 2017

title

Plant-based oral delivery of β-glucocerebrosidase as an enzyme replacement therapy for Gaucher's disease (English)

1 reference

enzyme replacement therapy

29 September 2017

main subject

0 references

1 reference

Yoseph Shaaltiel

1

1 reference

29 September 2017

Svetlana Gingis-Velitski

2

1 reference

29 September 2017

Salit Tzaban

3

1 reference

29 September 2017

Nadia Fiks

4

1 reference

29 September 2017

Yoram Tekoah

5

1 reference

29 September 2017

David Aviezer

6

1 reference

29 September 2017

publication date

1 April 2015

1 reference

Plant Biotechnology Journal

29 September 2017

published in

1 reference

29 September 2017

volume

13

1 reference

29 September 2017

issue

8

1 reference

29 September 2017

page(s)

1033-1040

1 reference

Plant-made subunit vaccine against pneumonic and bubonic plague is orally immunogenic in mice

29 September 2017

cites work

1 reference

A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes

21 January 2018

1 reference

Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts.

21 January 2018

1 reference

Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells

21 January 2018

1 reference

A plant-derived recombinant human glucocerebrosidase enzyme--a preclinical and phase I investigation

21 January 2018

1 reference

Gaucher disease and its treatment options

21 January 2018

1 reference

Low-cost production of proinsulin in tobacco and lettuce chloroplasts for injectable or oral delivery of functional insulin and C-peptide

21 January 2018

1 reference

Adaptation of the exocrine pancreas to diet

21 January 2018

1 reference

Minimizing the immunogenicity of protein therapeutics

21 January 2018

1 reference

A fusion protein derived from plants holds promising potential as a new oral therapy for type 2 diabetes

21 January 2018

1 reference

A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules

21 January 2018

1 reference

Chloroplast-derived vaccine antigens and other therapeutic proteins

21 January 2018

1 reference

Plant-made vaccine antigens and biopharmaceuticals

21 January 2018

1 reference

Crossing the barrier: Targeting epithelial receptors for enhanced oral vaccine delivery.

21 January 2018

1 reference

Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms

21 January 2018

1 reference

Plant-based production of biopharmaceuticals

21 January 2018

1 reference

Taliglucerase alfa: an enzyme replacement therapy using plant cell expression technology

21 January 2018

1 reference

Oral delivery of therapeutic proteins and peptides: a review on recent developments

21 January 2018

1 reference

Dietary proteins as determinants of metabolic and physiologic functions of the gastrointestinal tract

21 January 2018

1 reference

Oral delivery of bioencapsulated exendin-4 expressed in chloroplasts lowers blood glucose level in mice and stimulates insulin secretion in beta-TC6 cells

21 January 2018

1 reference

Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells

21 January 2018

1 reference

Protein drug oral delivery: the recent progress

21 January 2018

1 reference

Receptor-mediated oral delivery of a bioencapsulated green fluorescent protein expressed in transgenic chloroplasts into the mouse circulatory system

21 January 2018

1 reference

Induction of oral tolerance to prevent diabetes with transgenic plants requires glutamic acid decarboxylase (GAD) and IL-4.

21 January 2018

1 reference

Is the oral route possible for peptide and protein drug delivery?

21 January 2018

1 reference

Oral Protein Therapy for the Future – Transport of Glycolipid-Modified Proteins: Vision or Fiction

21 January 2018

1 reference

Immunogenic measles antigens expressed in plants: role as an edible vaccine for adults

21 January 2018

1 reference

Use of simulated intestinal fluids with Caco-2 cells and rat ileum

21 January 2018

1 reference

Drug carriers for oral delivery of peptides and proteins: accomplishments and future perspectives.

21 January 2018

1 reference

Gaucher disease: a comprehensive review

21 January 2018

1 reference

Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts--oral administration protects against development of insulitis in non-obese diabetic mice

21 January 2018

1 reference

Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system

21 January 2018

1 reference

Suppression of inhibitor formation against FVIII in a murine model of hemophilia A by oral delivery of antigens bioencapsulated in plant cells

21 January 2018

1 reference

Glycosylation and functionality of recombinant β-glucocerebrosidase from various production systems

21 January 2018

1 reference

Tobacco, a highly efficient green bioreactor for production of therapeutic proteins

21 January 2018

1 reference

Optimization and validation of two miniaturized glucocerebrosidase enzyme assays for high throughput screening

21 January 2018

1 reference

Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice

21 January 2018

1 reference

A biologically active rhIGF-1 fusion accumulated in transgenic rice seeds can reduce blood glucose in diabetic mice via oral delivery

21 January 2018

1 reference

How I treat Gaucher disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/PBI.12366

1 reference

29 September 2017

1 reference